Tramadol and Acute Kidney Injury
Mechanism and Risk
- Tramadol is primarily eliminated through renal excretion and should be avoided in patients with significant renal impairment unless no alternatives exist, as recommended by the American Society of Clinical Oncology 1, 2
- The American Society of Clinical Oncology recommends avoiding tramadol in patients with renal impairment due to its potential to cause acute kidney injury and accumulation of active metabolites 1, 2
Guidelines for Tramadol Use in Renal Impairment
- For patients with renal impairment, guidelines strongly recommend avoiding tramadol and using alternative opioids, such as methadone, which is preferred due to its fecal excretion, as suggested by the American Society of Clinical Oncology 1, 2
- More frequent clinical observation and dose adjustment are necessary when using any opioid in patients with renal impairment, according to the American Society of Clinical Oncology 2
- Fentanyl, oxycodone, and hydromorphone can be used with careful titration and frequent monitoring in renal impairment, as recommended by the American Society of Clinical Oncology 2
- Morphine, meperidine, and codeine should also be avoided in renal impairment due to accumulation of active metabolites, as suggested by the American Society of Clinical Oncology 2
Clinical Considerations
- Concomitant use of other nephrotoxic medications significantly increases AKI risk, as reported by the Kidney International journal 3
- Advanced age requires lower dosing due to increased risk of adverse effects, including renal complications, according to the Journal of the National Comprehensive Cancer Network 4
- Kidney function should be monitored in all patients exposed to potentially nephrotoxic agents like tramadol, as recommended by the Kidney International journal 3
- Patients receiving three or more nephrotoxic drugs simultaneously are at significantly higher risk for developing AKI, as reported by the Kidney International journal 3